Literature DB >> 30510152

A Spontaneous Regression of an Isolated Lymph Node Metastasis from a Primary Unknown Merkel Cell Carcinoma in a Patient with an Idiopathic Hyper-Eosinophilic Syndrome.

Raffaele Longo1, Oana Balasanu2, Mathilde Chastenet de Castaing1, Eric Chatelain3, Mohammed Yacoubi4, Marco Campitiello1, Nathalie Marcon5, Francesca Plastino1.   

Abstract

BACKGROUND Merkel cell carcinoma (MCC) is a rare, aggressive primary cutaneous neuroendocrine tumor frequently associated with Merkel cell polyomavirus infection. Despite its aggressiveness, a few reports of spontaneous MCC regression have been described in the literature, most of them following incisional biopsy supporting a hypothetical role of surgery-induced inflammation in the process of regression. CASE REPORT We report a case of 69-year-old Caucasian male who was followed for an idiopathic hyper-eosinophilic syndrome. A positron emission tomography (PET) scan documented a hyper-metabolic, left, inguinal adenopathy, histologically corresponding to a metastasis of a poorly differentiated neuroendocrine carcinoma. This lesion spontaneously regressed at clinical examination and radiological imaging. After its excisional dissection, histology was negative. Five months later, a nearby adenopathy reappeared. The patient underwent another excisional biopsy. Histology and immunohistochemistry were compatible with a lymph node metastasis of a MCC. As the patient refused radical surgery, a regional radiotherapy was performed. As of a follow-up at 10 months, he was alive and free of tumor recurrence. The hyper-eosinophilic syndrome was stable; however, the serum levels of chromogranin-A were inexplicably elevated in the absence of any tumor evidence at the PET scan. CONCLUSIONS The particularity of this case relies on the rarity of MCC complete spontaneous regression in a patient without a primary tumor and with a synchronous, idiopathic hyper-eosinophilic syndrome.

Entities:  

Mesh:

Year:  2018        PMID: 30510152      PMCID: PMC6287448          DOI: 10.12659/AJCR.911840

Source DB:  PubMed          Journal:  Am J Case Rep        ISSN: 1941-5923


Background

Merkel cell carcinoma (MCC) is a rare, aggressive primary cutaneous neuroendocrine tumor typically occurring on the head and neck of the elderly and generally presenting a poor prognosis [1-3]. Merkel cell polyomavirus (MCPyV) has been identified in up to 80% of cases suggesting its potential role in MCC tumorigenesis [4]. Despite its aggressiveness, a few reports of MCC complete spontaneous regression have been described in the literature, most of them following incisional biopsy, thus supporting the hypothetical role of surgery-induced inflammation in the regression process [5-24]. We report a rare case of an isolated, inguinal lymph node metastasis from a primary unknown MCC, spontaneously regressing after an ultrasound-guided core needle biopsy with a relapse in a nearby lymph node 5 months later, in a patient presenting with synchronous, idiopathic hyper-eosinophilic syndrome.

Case Report

We report on the case of a 69-year-old Caucasian male who was a smoker and who was regularly followed for an idiopathic hyper-eosinophilic syndrome. The patient had ischemic cardiovascular disease, mellitus diabetes, arterial hypertension, and dyslipidemia as relevant comorbidities. The patient’s history was uneventful, and he was asymptomatic. Clinical examination found a hard, irregular, left, inguinal lymph node of 1.5×1.5 cm of diameter. The positron emission tomography (PET) scan confirmed the presence of an isolated, hyper-metabolic, inguinal adenopathy of 1.9 cm (Figure 1). The patient was referred for a percutaneous ultrasound-guided core biopsy, which revealed a metastasis of a poorly differentiated neuroendocrine carcinoma. The immunohistochemical staining of the biopsy showed that tumor cells were negative for cytokeratin 7 (CK-7), p40, thyroid transcription factor 1 (TTF-1), prostate-specific antigen (PSA), chromogranin-A, weakly positive for cytokeratin 20 (CK-20), moderately positive for synaptophysin, and strongly positive for CD56. The Ki-67 was elevated at 95%. Biochemical tests were in the normal range, but chromogranin-A was persistently elevated at 1400 ng/mL (normal value <101.9 ng/mL). Abdominal and pelvic ultrasound showed a polypoid tumor lesion of the left bladder wall of 2.1×1.5×2.0 cm. Cystoscopy found a low-grade, papillary, noninfiltrating urothelial carcinoma that was completely resected (pTa). Colonoscopy revealed 4 tubular adenomas with a low-grade dysplasia, which were radically resected.
Figure 1.

Positron emission tomography scan documents an isolated left, hyper-metabolic, inguinal lymph node lesion (red arrows).

In March 2017, an excisional, inguinal lymph node biopsy was programmed but clinical examination showed a complete regression of the lesion, confirmed by a PET scan revealing a residual, not hyper-metabolic adenopathy (Figure 2), histologically corresponding to a lymph node with a central sclero-hyalinosis and a normal cortex in the absence of any tumor infiltration (Figure 3). Five months later, another left, inguinal lymph node was clinically documented and confirmed by a PET scan, showing a hyper-metabolic adenopathy of 1.2 cm (Figure 4). The patient underwent another excisional biopsy. Histology revealed a massive infiltration of poorly differentiated, small, neuroendocrine tumor cells with a scant cytoplasm and prominent mitotic figures (Figure 5). Immunohistochemistry showed that tumor cells were positive for CD56 (Figure 6), synaptophysin, and cytokeratin AE1/AE3, and negative for CK-7, CK-20, chromogranin-A, and CM2B4 (anti-polyomavirus), according with the diagnosis of MCC metastasis.
Figure 2.

Positron emission tomography scan, performed after the percutaneous, ultrasound-guided core needle biopsy and before the tumor excisional biopsy, reveals a residual, non hyper-metabolic adenopathy (red arrows).

Figure 3.

Histology shows a lymph node central sclero-hyalinosis with a normal cortex in the absence of any tumor infiltration (hematoxylin and eosin stain, 100×).

Figure 4.

Positron emission tomography scan confirms the presence of a new, inguinal, hyper-metabolic lymph node (red arrows).

Figure 5.

Histology reveals a massive tumor infiltration of poorly differentiated cells with scant cytoplasm, coarse chromatin, prominent mitotic and apoptotic figures, associated to a diffuse necrosis (hematoxylin and eosin stain, 100×).

Figure 6.

At the immunohistochemistry, tumor cells are positive for CD56 (400×).

As the patient refused the radical lymph node dissection, a regional radiotherapy was performed (50 Gy/25 fractions). Ten months later, the patient was in good clinical conditions and free of tumor recurrence. The hyper-eosinophilic syndrome was stable; however, the serum levels of chromogranin-A were inexplicably elevated in the absence of any tumor evidence at the PET scan.

Discussion

First described by Toker in 1972 as “trabecular carcinoma” of the skin [1], MCC is an aggressive neuroendocrine skin tumor most commonly appearing on sun-exposed areas, particularly in the head and neck region [1-3]. MCC presents a poor prognosis, with a 5-year overall survival of 60% [3]. At diagnosis, the involvement of regional lymph nodes is reported in 10–45% of the cases and is strongly related to the prognosis [3]. Distant metastases have been described in 50% of patients, the common sites being lymph nodes, liver, bone, brain, lung, and skin [3]. The incidence of MCC has tripled over the last 15 years [3]. A new human polyomavirus (Merkel cell polyomavirus: MCPyV) was detected in 2008 in 80% of MCC tumors and subsequently confirmed by many studies [4]. Its role in MCC prognosis is still controversial and not well established [4]. The risk for MCC is highly increased in patients with chronic T-cell dysfunctions such as solid organ transplantation, HIV infection, and chronic lymphocytic leukemia [1-3]. Despite its aggressiveness, several reports have documented MCC complete spontaneous regression in the absence of any specific treatment [5-24]. First described by O’Rouke and Bell in 1986 [5], MCC complete spontaneous regression accounts for approximately 1.4% of all reported cases (15 out of 1100) as compared to all other cancers, which present an incidence rate of 1 out of 60 000 to 100 000 [5-24]. Interestingly, MCC complete spontaneous regression typically has rapid onset (1 to 5 months) and is persistent, with a few reported cases of recurrence; it occurs more frequent in women, and is usually associated with better disease-specific survival [5-24]. The complete spontaneous regression pathogenesis remains unclear. It has been suggested that T-cell-mediated immunity could play an important role in complete spontaneous regression pathogenesis. Several histopathologic studies showed accumulation of chronic inflammatory cells, mainly T-cells and foamy macrophages, after tumor biopsy. Furthermore, T-cell-related cytokines, such as interferons, can promote effective immune responses against neuroendocrine tumors [24-28]. Several reports suggest a potential role for diagnostic biopsy that could stimulate a T-cell mediated immune response, but data concerning the prognostic value of intra-tumoral and/or peri-tumoral CD8+ lymphocyte infiltration are still controversial [24-28].

Conclusions

In our case, the patient presented with a spontaneous regression of an isolated inguinal lymph node metastasis from an unknown primary MCC after a percutaneous, ultrasound-guided core needle biopsy, with a relapse in a nearby lymph node 5 months later. The particularity of this case relies on the rarity of the MCC complete spontaneous regression in a patient without a primary tumor, which probably spontaneously regressed, and who had a synchronous idiopathic hyper-eosinophilic syndrome.
  27 in total

1.  Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon?

Authors:  G Sais; C Admella; T Soler
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-01       Impact factor: 6.166

Review 2.  Complete spontaneous regression of Merkel cell carcinoma: a review of the 10 reported cases.

Authors:  T J Connelly; B Cribier; T J Brown; I Yanguas
Journal:  Dermatol Surg       Date:  2000-09       Impact factor: 3.398

3.  Spontaneous regression in merkel cell carcinoma: report of two cases with a description of dermoscopic features and review of the literature.

Authors:  Cristina Ciudad; Jose Antonio Avilés; Fernando Alfageme; Manuel Lecona; Ricardo Suárez; Pablo Lázaro
Journal:  Dermatol Surg       Date:  2010-04-01       Impact factor: 3.398

4.  Complete spontaneous regression of metastatic merkel cell carcinoma: a case report and review of the literature.

Authors:  J C Wooff; J R Trites; N M G Walsh; M J Bullock
Journal:  Am J Dermatopathol       Date:  2010-08       Impact factor: 1.533

5.  Complete spontaneous regression of Merkel cell carcinoma.

Authors:  Luis Junquera; Aintza Torre; Juan C Vicente; Luis García-Consuegra; Manuel F Fresno
Journal:  Ann Otol Rhinol Laryngol       Date:  2005-05       Impact factor: 1.547

6.  Spontaneous regression of recurrent and metastatic Merkel cell carcinoma.

Authors:  Hidemichi Kubo; Shigeto Matsushita; Tomoko Fukushige; Tamotsu Kanzaki; Takuro Kanekura
Journal:  J Dermatol       Date:  2007-11       Impact factor: 4.005

7.  Spontaneous complete regression in merkel cell carcinoma after biopsy.

Authors:  José Fernando Val-Bernal; Almudena García-Castaño; Rosario García-Barredo; Rosa Landeras; Ana De Juan; María Francisca Garijo
Journal:  Adv Anat Pathol       Date:  2011-03       Impact factor: 3.875

Review 8.  Merkel cell carcinoma. Pathological and molecular aspects of diagnosis and clinical features.

Authors:  Hanna Majewska; Wojciech Biernat
Journal:  Pol J Pathol       Date:  2010       Impact factor: 1.072

Review 9.  Regressing Merkel cell carcinoma-a case showing replacement of tumour cells by foamy cells.

Authors:  K Maruo; K I Kayashima; T Ono
Journal:  Br J Dermatol       Date:  2000-06       Impact factor: 9.302

10.  Spontaneous regression of Merkel cell carcinoma of the nose.

Authors:  Petros D Karkos; Anand Sastry; Sucha Hampal; Mohammad Al-Jafari
Journal:  Head Neck       Date:  2010-03       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.